authors
- Fields, Jerel Adam
- Masliah, Eliezer
- Achim, Cristian L
- Desplats, Paula
- Spencer, Brian
- Swinton, Mary
- Qvale, Emma Martine
- Maria J. Marquine, PhD
- Alexeeva, Arina
- Gough, Sarah
- Soontornniyomkij, Benchawanna
- Valera, Elvira
Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2018
published in
- Journal of neurochemistry Journal
has subject area
- AIDS Dementia Complex
- Adult
- Amyloid beta-Peptides
- Antiretroviral Therapy, Highly Active
- Biomarkers
- Brain Chemistry
- Cognition Disorders
- Ethnicity
- Female
- HIV Seropositivity
- Hispanic or Latino
- Humans
- Male
- Membrane Glycoproteins
- Microglia
- Middle Aged
- Neuropsychological Tests
- RNA, Messenger
- Receptors, Immunologic
- Retrospective Studies
- Tumor Necrosis Factor-alpha